Agenus reported $-41652000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US USD -41652000 3.32M
Amgen AMGN:US USD 2.66B 71M
AstraZeneca AZN:LN USD 2.26B 427M
Bristol Myers Squibb BMY:US USD 2.74B 461M
CSL CSL:AU USD 881.4M 1.51B
Eli Lilly And LLY:US USD 1.95B 294.9M
Genocea Biosciences GNCA:US USD -15773000 2.36M
Gilead Sciences GILD:US USD 2.81B 784M
Glaxosmithkline GSK:US GBP 2.41B 591M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Immunogen IMGN:US USD -77429000 16.38M
Intrexon XON:US USD -7614000 15.91M
Jiangsu Hengrui Me. 600276:CH CNY 1.07B 234.47M
Johnson & Johnson JNJ:US USD 6.77B 173M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merck MRK:GR EUR 1.35B 3M
Merk MRK:US USD 5.56B 156M
Northwest Biotherapeutics NWBO:US USD -15618000 5.48M
Novartis NOVN:VX USD 3.33B 8M
Pfizer PFE:US USD 9.7B 2.43B
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Veracyte VCYT:US USD -9680000 2.25M
YTE INCY:US USD 118.25M 142.04M